![](https://www.cancer.gov/sites/g/files/xnrzdm211/files/styles/cgov_social_media/public/cgov_image/media_image/2024-07/NSCLC-brain-mets-horizontal.png)
Lorlatinib Slows Growth of ALK-Positive Lung Cancers, May Prevent Brain Metastases
July 10, 2024, by Edward Winstead Lung cancers that are ALK-positive often spread to the brain (circled). In the CROWN trial, treatment with lorlatinib helped prevent new brain metastases. Credit: Gaillard F, Cerebral - Radiopaedia.org. https://doi …